NCT07255963
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Clinical trial condition
Histiocytosis
Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.
406 public trials
82 recruiting studies
Histiocytosis trial results
NCT05768178
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- University Hospital Birmingham Birmingham, United Kingdom
- Bristol Haematology and Oncology Centre Bristol, United Kingdom
- Addenbrooke's Hospital Cambridge, United Kingdom
NCT06712810
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, Bone Marrow Diseases, +87 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT05940272
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (All protocol activities) New York, United States
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only) New York, United States
Recruiting
Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease
NCT07187167
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Non-Langerhans-Cell, +3 more
- Locations
-
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China
NCT07187193
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
- Locations
-
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China
Recruiting
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
NCT04079179
- Conditions
- Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +18 more
- Locations
-
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Benioff Children's Hospital San Francisco, California, United States
Recruiting
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
NCT02670707
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
- Locations
-
- Stanford Children's Hospital, Lucile Packard Children's Hospital Palo Alto, California, United States
- Rady Children's Hospital - San Diego San Diego, California, United States
- University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
- Nationwide Children's Hospital Columbus, Ohio, United States
NCT05146336
- Conditions
- Acute Liver Failure, Acute Respiratory Distress Syndrome, Acute on Chronic Liver Failure, +60 more
- Locations
-
- Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria
- Medizinische Universität Wien Vienna, Austria
- Universitätsklinikum Aachen Aachen, Germany
- Herz- und Diabeteszentrum Nordrhein-Westfalen Bad Oeynhausen, Germany
NCT07057765
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University Cairo, Cairo Governorate, Egypt